Skip to main content

Table 2 The number of synergistic and antagonistic combination with clarithromycin and each antimicrobial

From: The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex

  

CLR/AMK

CLR/IPM

CLR/MXF

 

Species

Categories of FIC index

N (%, Adjusted residual)

p value

M.abscessus complex

Synergy + Additive

5 (17.2, − 1.5)

14 (48.3, 3.1**)

5 (17.2, − 1.5)

0.001**

N = 29†

Indifference + Antagonism

24 (82.8, 1.5)

15 (51.7, − 3.1**)

24 (82.8, 1.5)

 

M. abscessus subsp. massiliense

Synergy + Additive

3 (16.7, −1.3)

9 (50.0, 2.6**)

3 (16.7, − 1.3)

0.036*

N = 18

Indifference + Antagonism

15 (83.3, 1.3)

9 (50.0, −2.6**)

15 (83.3, 1.3)

 

M. abscessus subsp. abscessus

Synergy + Additive

2 (20.0, −0.8)

5 (50.0, 1.7)

2 (20.0, −0.8)

0.24

N = 10

Indifference + Antagonism

8 (80.0, 0.8)

5 (50.0, −1.7)

8 (80.0, 0.8)

 
  1. † including M. abscessus subsp. boletii (n = 1)
  2. * p value < 0.05, ** p value < 0.01
  3. * adjusted residuals > |1.96|, ** adjusted residuals > |2.58|
  4. Abbreviations: FIC index fractional inhibitory concentration index, CLR clarithromycin, AMK amikacin, IPM imipenem, MXF moxifloxacin